Research Article
A Higher Frequency of CD4+CXCR5+ T Follicular Helper Cells in Adult Patients with Minimal Change Disease
Table 3
The effect of PDN treatment on the values of clinical measures in MCD patients.
| | | Before PDN treatment | After PDN treatment |
| | Age, years | 48 (38–62) | 48 (38–62) | | Female/male | 1/3 | 1/3 | | Urinary protein, g/24 h | 16.31 (6.00–19.22) | 2.78 (1.36–5.27)* | | Serum uric acid, mol/L | 365 (257–441) | 349 (245–421) | | Triglycerides, mmol/L | 2.71 (1.55–3.06) | 1.62 (1.21–2.85) | | Cholesterol, mmol/L | 10.45 (6.20–11.57) | 8.97 (5.67–10.23) | | eGFR, mL/min/1.73 m2 | 102.36 (94.85–115.3) | 96.43 (74.3–113) | | Serum albumin, g/L | 15.0 (11–20.9) | 16.72 (15.3–26.4) | | Microscopic hematuria, rbc/hpf | 3.2 (2.1–9.6) | 1.18 (0.4–2.5) | | WBC, 109/L | 6.9 (5.32–22.99) | 5.79 (4.87–7.34) | | Lymphocytes, 109/L | 3.14 (1.74–12.90) | 1.52 (0.67–2.83) |
|
|
Data are presented as median (range). versus the values before PDN treatment.
|
